SARS-CoV-2 mRNA vaccination induces robust humoral and cellular immunity in the
circulation; however, it is currently unknown whether it elicits effective immune responses in the …

Rationale: An efficacious medical therapy for idiopathic pulmonary fibrosis (IPF) remains
elusive. Objectives: To explore the efficacy and safety of etanercept in the treatment of IPF. …

Objective: To define the prognosis for and radiographic presentation of patients with pulmonary
amyloidosis. Design: Retrospective review of the Mayo Clinic experience with biopsy-…

Background Tumor necrosis factor (TNF)-α is produced by macrophages and other cells,
and is believed to participate in granulomatous inflammation. Targeted antagonism of TNF-α …

Objectives To evaluate experience with the flexible bronchoscopic management of
tracheobronchial foreign bodies (TFBs) in children (age ≤ 16 years). Design All pediatric …

Objective To characterize the epidemiology of sarcoidosis from 1946 through 2013. Patients
and Methods An inception cohort of patients with incident sarcoidosis from January 1, 1976, …

… Author links open overlay panel David Dingli MD a , James P. Utz MD, FCCP b , Michael
J. … (15.4%) were treated with radioactive phosphorus ( 32 P), 3 patients (11.5%) received …

Idiopathic pulmonary fibrosis (IPF) occurs predominantly in middle-aged and older adults and
accounts for 20% to 30% of interstitial lung diseases. It is usually progressive, resulting in …

Rationale: Computed tomography (CT) scanning of the lung may reduce phenotypic
heterogeneity in defining subjects with chronic obstructive pulmonary disease (COPD), and allow …

Rationale: Patients with severe chronic obstructive pulmonary disease (COPD) may have
varying levels of disability despite similar levels of lung function. This variation may reflect …